BC Innovations | May 3, 2012
Cover Story

Heart beats fat

Researchers from The University of Texas Southwestern Medical Center have discovered that knocking down microRNA-208a in the heart leads to systemic benefits in obesity and metabolic disease, in addition to the already known effects on...
BC Innovations | May 3, 2012
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Metabolic syndrome; obesity MicroRNA-208a (miR-208a) Studies in mice suggest antagonizing miR-208a could help treat metabolic syndrome and obesity. In a mouse model of diet-induced...
Items per page:
1 - 2 of 2